FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1245311000001106: Metolazone 5mg tablets 100 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22037501000001116 Metolazone 5mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22037601000001117 Metolazone 5mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metolazone 5mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet Is pack of Product containing precisely metolazone 5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet Has active ingredient Metolazone false Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet Has VMP Product containing precisely metolazone 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet Has specific active ingredient Metolazone true Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Metenix 5 tablets (Borg Medicare Ltd) 100 tablet 10 x 10 tablets Is a True Metolazone 5mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start